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ABSTRACT There has been a resurgence of syphilis diagnoses in Australia. We in-
vestigated whether our Treponema pallidum PCR test provides any additional diag-
nostic information over syphilis serology (chemiluminescence immunoassay [CMIA],
Treponema pallidum particle agglutination [TPPA] assay, and the rapid plasma reagin
[RPR] ﬂocculation test). A retrospective audit of all T. pallidum PCR requests that
came through our laboratory from January 2010 to June 2017 was conducted; data
collected included age, gender, site of swab, and results from T. pallidum PCR, syphi-
lis serology, and herpes simplex virus 1 (HSV-1) and HSV-2 PCRs. A total of 441 T.
pallidum PCR tests were performed; on average, 3 T. pallidum PCRs per month were
requested in 2011, and this rate increased to 17.2 requests per month in 2017. A to-
tal of 323 patients had both T. pallidum PCR and syphilis serology performed, with
67% of swabs taken from the genitals. T. pallidum PCR gave positive results for 61/
323 (19%) patients; of these 61 patients, 59 (97%) also had positive syphilis serology
results (T. pallidum PCR sensitivity, 68%; speciﬁcity, 99%; positive predictive value,
97%; negative predictive value, 89%). Syphilis serology was positive for 91/323 pa-
tients (28%); of these 91 patients, 61 (66%) were also T. pallidum PCR positive (syphi-
lis serology sensitivity, 97%; speciﬁcity, 88%; positive predictive value, 60%; negative
predictive value, 99%). The Cohen’s kappa value was 0.74, indicating substantial
agreement between the two tests. Our results show that most patients with positive
T. pallidum PCR results also had positive syphilis serology. Therefore, T. pallidum PCR
adds little clinical value over serology for the diagnosis of syphilis in certain clinical
settings.
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Syphilis is a sexually transmitted disease caused by the spirochete Treponemapallidum. It has varied disease manifestations and is classically divided into three
distinct stages: primary, secondary, and tertiary syphilis (1). There has been a resur-
gence of syphilis in Australia. This has occurred largely in the metropolitan areas,
predominantly among men who have sex with men (MSM), but now syphilis is also
increasing in regional indigenous communities, particularly among adolescents and
young adults (2–4).
The diagnosis of syphilis remains a challenge. Serology has emerged as the mainstay
of syphilis diagnosis and is divided into treponemal and nontreponemal tests. The
nontreponemal tests are the rapid plasma reagin (RPR) and Venereal Disease Research
Laboratory (VDRL) tests. These deﬁne disease activity but suffer from poor speciﬁcity.
Treponemal tests detect antibodies to treponema species and are used to conﬁrm the
presence of a treponemal infection. These include the chemiluminescence immunoas-
say (CMIA), Treponema pallidum hemagglutination (TPHA) assay, and Treponema palli-
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dum particle agglutination (TPPA) assay. Their sensitivities and speciﬁcities are not
affected by the activity of the infection, and these tests remain positive for life (5, 6).
Although serological tests are very sensitive at diagnosing secondary syphilis, some
studies have estimated the sensitivity of serology for diagnosing primary syphilis at
86% (5). This is due to a window period whereby the humoral response to syphilis
develops 1 to 4 weeks after the chancre forms in primary syphilis (7). PCR tests have
been developed to aid in the diagnosis of early, primary syphilis. These tests have
proven to be both sensitive and speciﬁc for primary syphilis but less sensitive for
secondary syphilis (8, 9). Further studies have also indicated that PCR may in fact be
more sensitive than serology in early, primary syphilis and suggest that PCR is a
necessary adjunct to serological testing to ensure that no patients in the “window
period” are missed (10).
Our laboratory introduced an in-house T. pallidum PCR test in 2001, but this test was
widely adopted only in 2010. Serology is usually performed concurrently with the PCR
test. The T. pallidum PCR test is performed in the central laboratory in Brisbane,
Australia, 1,400 km away from our facility, increasing turnaround time and costs
associated with the transport of specimens. Serology is performed in our local Towns-
ville laboratory. This duplication in testing (i.e., serology plus PCR), in addition to the
increased specimen handling and transport, more than doubles the cost of syphilis
screening and diagnosis, from AUS$25 to AUS$60, on conservative estimates based on
the typical costs billed by our facility. For this reason, and because of increasing
requests for syphilis PCR, we decided to conduct a study looking at whether the
addition of the PCR test resulted in any extra diagnoses of primary syphilis, or whether
positive patients would have been captured regardless with positive serological tests.
MATERIALS AND METHODS
Study population. The Pathology Queensland (QLD) laboratory at the Townsville hospital is one of
a network of 35 public hospital laboratories. In addition to providing laboratory services to the 600-bed
Townsville hospital, the laboratory also provides diagnostic services to hospitals and health care facilities
across North Queensland, in the northeast of Australia. Some PCR tests, including the T. pallidum PCR, are
performed by the central Pathology QLD laboratory in Brisbane. Clinical samples in this study came from
hospitals and sexual health services in the city of Townsville, as well as the surrounding towns of Ayr,
Palm Island, Mornington Island, Hughenden, Mount Isa, Charters Towers, and Doomadgee.
Study design and clinical deﬁnitions. A retrospective review of the results of T. pallidum PCR
requests from 2010 to 2017 was performed. We used an extended search of our results database,
“AUSLAB,” with requests for T. pallidum PCR from 2010 to 2017 as the primary ﬁlter. Patients 18 years
old, and those whose swabs were from placentas, were excluded. The results of serology performed
within 14 days of the T. pallidum PCR, as well as age, gender, the site of the swab, and the results of
herpes simplex virus 1 (HSV-1) and HSV-2 PCRs performed on the same swab were also collected.
Prospective approval for this audit was granted by the Townsville Hospital and Health Service Human
Research Ethics Committee (HREC/17/QTHS/87).
T. pallidum PCR testing. Swabs of lesions were sent either in dry sterile containers or in vials
containing viral transport medium. If a swab was sent for T. pallidum PCR, it was assumed that there was
a clinical lesion suggestive of a chancre. PCR testing was performed at the Pathology QLD laboratory in
Brisbane. DNA was extracted from swab samples by use of the MagNA Pure 96 system (Roche Applied
Science, Indianapolis, IN). The PCR targeted the T. pallidum 47-kDa integral membrane lipoprotein gene
and was based on a previously described method (11). Ampliﬁcation and detection were achieved on the
Rotor-Gene Q real-time PCR instrument (Qiagen, Victoria, Australia).
Syphilis serology testing. Syphilis serology was performed on sera at the Pathology QLD laboratory
at the Townsville hospital. The initial test was a Treponema pallidum chemiluminescence immunoassay
(CMIA) performed on the commercially available Architect analyzer (Abbott Diagnostics, Lake Bluff, IL) as
per the manufacturer’s instructions. If the result was positive by CMIA, a Treponema pallidum particle
agglutination (TPPA) assay was performed with the Serodia-TP-PA test kit (Fujirebio, Tokyo, Japan)
according to the manufacturer’s instructions to conﬁrm the result, and a quantitative rapid plasma reagin
(RPR) ﬂocculation test was performed with the BD Macro-Vue RPR card test kit (Thermo Fisher Scientiﬁc,
Waltham, MA, USA) as per the manufacturer’s instructions. The syphilis serology was considered positive
and consistent with a new diagnosis of syphilis if the patient had positive reactive treponemal tests
(CMIA and TPPA), with or without a positive RPR test result. Serology was considered positive and
consistent with new infection if the patient had positive CMIA and TPPA results recorded previously and
the RPR was 4-fold higher than that previously recorded (5, 7). If the CMIA result was positive and the
TPPA and RPR results were negative, we attached a comment stating that this might be a false-positive
result and suggesting repeat testing in 2 to 4 weeks.
Statistical analysis. Descriptive and regression statistics were performed using Stata 13 (StataCorp,
College Station, TX, USA). The sensitivities, speciﬁcities, positive predictive values, and negative predictive
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values of both the T. pallidum PCR and syphilis serology tests were evaluated by using each test as the
gold standard for the other.
A kappa value was calculated to measure the level of agreement between the two tests, T. pallidum
PCR and syphilis serology. Categorical data were tested using the chi-square test for dependence; a P
value of 0.05 was considered signiﬁcant.
RESULTS
There were 516 requests for T. pallidum PCRs, on 493 unique patients, between
January 2010 and May 2017. Of these, 75 were excluded. Reasons for exclusion were an
age of 18 years (based on the recommendations of our local Ethics Committee) (51
patients), cancellation of the test prior to performance (11 patients), and performance
of the test to investigate congenital syphilis (13 patients). There were, on average, 3
requests for T. pallidum PCR per month in 2011, and this rate increased to 17.2 per
month in 2017 (Fig. 1).
Of the 441 patients who had swabs tested for T. pallidum PCR, 323 (73%) also had
syphilis serology performed within 14 days. These were the patients included in our
analysis.
The median patient age was 29 years (interquartile range [IQR], 23 to 37 years), and
197/323 (61%) were male. The swabs were taken predominantly from the genital region
(Table 1). A summary of the T. pallidum PCR, serological, and herpes simplex virus 1
(HSV-1) and HSV-2 PCR results is provided in Table 2.
T. pallidum PCR was positive for 61/323 (19%) samples. Syphilis serology was positive
for 59 (97%) of these 61 PCR-positive samples. One of the two patients with a positive
T. pallidum PCR result and a negative syphilis serology (CMIA) result at baseline had
FIG 1 Average monthly rate of T. pallidum PCR requests by year.
TABLE 1 Sites of swabs taken for T. pallidum PCR
Site No. (%) of swabs
Genital 216 (67)
Anal 21 (7)
Oral 23 (7)
Othera 9 (3)
Ulcer/lesion with no site speciﬁed 40 (12)
No clinical information 14 (4)
Total 323 (100)
aIncludes thighs, groin, arms, face, and eyes.
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positive CMIA, equivocal TPPA, and negative RPR results when these tests were
performed 2 months later. The other patient had follow-up serology (CMIA) performed
at 1 month, which remained negative. Two months after this, the patient’s repeat CMIA
was positive, but TPPA and RPR remained negative. The T. pallidum PCR test had a
sensitivity of 68%, a speciﬁcity of 99%, a positive predictive value of 97%, and a
negative predictive value of 89% by use of syphilis serology as the gold standard
(Table 3).
Of 323 patients, 91 (28%) had positive syphilis serology, and 61 of these 91 patients
(66%) were also positive by the T. pallidum PCR (Table 3). Syphilis serology had a
sensitivity of 97%, a speciﬁcity of 88%, a positive predictive value of 60%, and a
negative predictive value of 99% by use of T. pallidum PCR as the gold standard. The
Cohen’s kappa value was 0.74, indicating substantial agreement between the two tests.
Of the 30 patients who were serology positive and PCR negative, 17 (57%) had an
TABLE 2 Summary of all results for the 323 patients tested both by T. pallidum PCR and
by serology
Pattern of results and
no. of samples
Result by:
Serologya PCR
CMIA TPPA RPR Consensusb T. pallidum HSV-1 HSV-2
T. pallidum PCR positive,
serology positive
1 Pos Pos NR Pos Pos N/P N/P
3 Pos Pos NR Pos Pos Neg Neg
11 Pos Pos Pos Pos Pos N/P N/P
39 Pos Pos Pos Pos Pos Neg Neg
7 Pos Pos Pos Pos Pos Neg Pos
T. pallidum PCR positive,
serology negative
(2)
Neg N/P N/P Neg Pos Neg Neg
T. pallidum PCR
negative, serology
positive
2 Pos Pos NR Pos Neg N/P N/P
4 Pos Pos NR Pos Neg Neg Neg
7 Pos Pos Pos Pos Neg N/P N/P
17 Pos Pos Pos Pos Neg Neg Neg
T. pallidum PCR
negative, serology
negative
42 N/A N/A N/A Neg Neg N/P N/P
119 N/A N/A N/A Neg Neg Neg Neg
15 N/A N/A N/A Neg Neg Pos Neg
53 N/A N/A N/A Neg Neg Neg Pos
1 N/A N/A N/A Neg Neg Pos Pos
aCMIA, chemiluminescence immunoassay; TPPA, Treponema pallidum particle agglutination; RPR, rapid
plasma reagin; Pos, positive; Neg, negative; NR, nonreactive; N/P, not performed; N/A, not applicable
(syphilis serology was assessed as negative due to a nonreactive CMIA, or serology that was reactive but
unchanged from a previous test result).
bSyphilis serology assessed as positive or negative based on previous results.
TABLE 3 Syphilis serology versus T. pallidum PCR results
Syphilis serology result
No. of patients:
With the following T. pallidum
PCR result
TotalPositive Negative
Positive 61 30 91
Negative 2 230 232
Total 63 260 323
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RPR titer of16, compared with 49 (80%) of the 61 patients who were serology positive
and PCR positive (P  0.023) (Fig. 2).
HSV-1 and HSV-2 PCR tests were performed for 260 of the 323 patients (80%) (Table
2). Overall, 5% of the patients were positive for HSV-1 and 20% for HSV-2. One patient
was positive for both HSV-1 and HSV-2, and seven patients were positive by both the
HSV-2 and T. pallidum PCRs.
DISCUSSION
The prevalence of syphilis has been increasing in recent times, which has resulted
in the need for our pathology service to provide syphilis diagnostic tests with accuracy
and precision that return results in a timely manner (2). The syphilis PCR test was
introduced in addition to syphilis serology in order to increase sensitivity in diagnosing
primary syphilis. This was due to the “window period” of the serological tests in early
disease (7); the sensitivity of syphilis serology is estimated at 86% for primary syphilis
(5). As can be seen from Fig. 1, the use of T. pallidum PCR in our laboratory has been
increasing. However, our results indicate that in our setting, the syphilis PCR test does
not add signiﬁcant diagnostic value. Syphilis serology demonstrated an excellent
negative predictive value (99%) in our study. Only 2/61 patients (3%) with positive
syphilis PCR results had negative serology at the time of diagnosis. One of these
patients had an equivocal TPPA result when serum was retested 2 months later, which
could be considered a positive syphilis serology result. It is reasonable, therefore, to
consider that this patient was in the serological window period at the time of initial
diagnosis and that the syphilis PCR yielded a true-positive result. However, the second
patient had a negative result by repeat CMIA 1 month after initial testing. Two months
after this, the patient’s repeat CMIA was positive but the TPPA and RPR remained
negative. This patient’s syphilis serology never became truly positive, and it is possible
that the original positive T. pallidum PCR result was false positive.
In contrast, other published studies, including a meta-analysis, have shown the value
of PCR in addition to serology, reporting that as many as 8% of patients with positive
T. pallidum PCR results had negative syphilis serology at the time of diagnosis (8, 10).
We postulate that our lower rate may be due to patients presenting later in the natural
history of their disease than in other settings. We provide pathology services to many
surrounding communities in which socioeconomic disadvantage and difﬁculty access-
ing health care have been shown to correlate with the prevalence of sexually trans-
mitted infections (12).
Syphilis serology showed poor positive predictive value (60%) in our study: 30
FIG 2 Rapid plasma reagin (RPR) values for all the patients with positive serological results. NR,
nonreactive.
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patients had positive syphilis serology and negative T. pallidum PCR results. This
resulted in a calculated sensitivity of 67% for the syphilis PCR test by use of syphilis
serology as the gold standard, which is lower than the 78.4% for ulcers in primary
syphilis reported from a recent meta-analysis (10). We postulate that this disagreement
between the two tests occurred for the following reasons. To conﬁrm that the positive
syphilis serology did indeed represent new infection, we could only check for past
syphilis results on our local pathology database. Theoretically, some of the positive
results could be due to past infection if previous positive serology was performed with
a different pathology service. In addition, we believe that since we had very little
corresponding clinical data, some of these serology-positive, PCR-negative results may
represent secondary syphilis, for which T. pallidum PCR testing has been shown to have
lower sensitivity (8, 9), or late latent infection. The RPR values were signiﬁcantly lower
(Fig. 2) (P  0.023) for serology-positive, PCR-negative patients than for serology-
positive, PCR-positive patients, also indicating less acute infection (5).
Our study also enabled us to view how clinicians are using the syphilis PCR test in
their diagnostic algorithms. A quarter of patients (26%) who had a syphilis PCR test
performed had no syphilis serology requested, including two patients with positive PCR
results. Australian and international guidelines recommend performing syphilis serol-
ogy at baseline so that the response to treatment can be monitored (https://www.cdc
.gov/std/syphilis/treatment.htm), and no guideline, to our knowledge, recommends
using syphilis PCR alone to diagnose primary syphilis. This suggests that we may need
to increase education for health professionals regarding this issue.
There has been a steady increase in the requests for syphilis PCR coming through
our laboratory (Fig. 1). At a cost of AUS$35 per test (not including transport and
processing costs), this means we now spend, on average, ca. AUS$7,000 a year on this
test, an amount that could increase signiﬁcantly if the rate of requests continues to
increase.
HSV-1 and -2 were shown to be important differentials for primary syphilis, with 25%
of samples testing positive for HSV-1 or -2. This ﬁnding is consistent with other reported
rates and conﬁrms the need to perform HSV-1 and -2 PCRs on genital lesions as well as
investigating for primary syphilis (8). Twenty percent of our patients did not have HSV-1
or -2 PCR tests requested.
We also noted that 7/61 (11%) T. pallidum PCR-positive patients had HSV-2–syphilis
coinfections. High rates of coinfection have been reported previously, particularly in
cohorts of men who have sex with men, and occur due to shared routes of sexual
transmission (13).
The major limitation of our study is the lack of clinical information with which we
could correlate our laboratory results, including human immunodeﬁciency virus (HIV)
status, whether the patients had acquired syphilis more than once, and whether any
had received prior antibiotic therapy. We assumed, for the purposes of this study, that
a swab of a lesion sent with a request for syphilis PCR was an investigation for a chancre
in primary syphilis. For this study, we had no means of assessing what these lesions
looked like, and how much they resembled a typical syphilitic lesion. We also had no
information on how long the lesion or symptoms had been present. Such information
would have allowed us to stage the condition as primary or secondary and to
understand whether patients were indeed presenting late in their illness. A further
limitation of this study is that we did not explore whether differences in PCR method-
ology affected the results. For example, previous studies have found that nested PCR,
or use of the polA gene (rather than the 47-kDa target used here), may enhance PCR
sensitivity (10).
In conclusion, we believe that the results of this study indicate that the addition of
syphilis PCR to serology in the diagnostic algorithm for primary syphilis may not be
necessary in our setting. We had a very low rate of positive syphilis PCR tests that were
not accompanied by positive syphilis serology. Since syphilis serology is recommended
to be performed at baseline to allow for monitoring of the response to treatment, it
seems reasonable to reconsider the need to perform a second diagnostic test, espe-
Brischetto et al. Journal of Clinical Microbiology
May 2018 Volume 56 Issue 5 e01782-17 jcm.asm.org 6
 o
n
 August 23, 2018 by guest
http://jcm.asm.org/
D
ow
nloaded from
 
cially in this age of increasing awareness of the need for pathology stewardship (14).
However, we acknowledge that other studies have shown different results, and we
advocate for individual health services to assess whether the syphilis PCR is necessary
in addition to serological testing.
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